Articles published by Atara Biotherapeutics, Inc.
![](https://mms.businesswire.com/media/20220217006012/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
Atara Biotherapeutics Provides Update on ATA2271 Autologous CAR T Trial
February 18, 2022
Via Business Wire
Tickers
ATRA
![](https://mms.businesswire.com/media/20220215006185/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20220207005829/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
February 07, 2022
Via Business Wire
Tickers
ATRA
![](https://mms.businesswire.com/media/20220126006000/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
Via Business Wire
Tickers
ATRA
![](https://mms.businesswire.com/media/20220122005025/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20220109005052/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20220106005632/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 07, 2022
Via Business Wire
Tickers
ATRA
![](https://mms.businesswire.com/media/20220104005891/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
Atara Biotherapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
January 05, 2022
Via Business Wire
Tickers
ATRA
![](https://mms.businesswire.com/media/20211213005973/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20211209005155/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20211203005319/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 03, 2021
Via Business Wire
Tickers
ATRA
![](https://mms.businesswire.com/media/20211130005204/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20211108006021/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
Via Business Wire
Tickers
ATRA
![](https://mms.businesswire.com/media/20211105005010/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 05, 2021
Via Business Wire
Tickers
ATRA
![](https://mms.businesswire.com/media/20211104005811/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20211104005358/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
Atara Biotherapeutics Announces Third Quarter 2021 Financial Results and Operational Progress
November 04, 2021
Via Business Wire
Tickers
ATRA
![](https://mms.businesswire.com/media/20211028006146/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
Atara Biotherapeutics to Announce Third Quarter 2021 Financial Results on Thursday, November 4, 2021
October 28, 2021
Via Business Wire
Tickers
ATRA
![](https://mms.businesswire.com/media/20211013005398/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20211004005257/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20211001005739/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
October 01, 2021
Via Business Wire
Tickers
ATRA
![](https://mms.businesswire.com/media/20210929005368/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20210927005248/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20210903005047/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
September 03, 2021
Via Business Wire
Tickers
ATRA
![](https://mms.businesswire.com/media/20210902005080/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
Atara Biotherapeutics to Participate in a Panel Discussion at the Citi 16th Annual BioPharma Virtual Conference
September 02, 2021
Via Business Wire
Tickers
ATRA
![](https://mms.businesswire.com/media/20210809005755/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
Atara Biotherapeutics Announces Second Quarter 2021 Financial Results and Operational Progress
August 09, 2021
Via Business Wire
Tickers
ATRA
![](https://mms.businesswire.com/media/20210809005701/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20210802005783/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 02, 2021
Via Business Wire
Tickers
ATRA
![](https://mms.businesswire.com/media/20210802005013/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
Atara Biotherapeutics to Announce Second Quarter 2021 Financial Results on Monday, August 9, 2021
August 02, 2021
Via Business Wire
Tickers
ATRA
![](https://mms.businesswire.com/media/20210702005339/en/792504/4/Atara-Bio1_logo_300x185-1.jpg)
Via Business Wire
Tickers
ATRA
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.